With offices and research and development facilities in the United States and Europe, Algenol’s operations, like its project development activities, have a global reach.
Algenol’s commercial development campus, built with assistance from Lee County, Florida, includes 40,000 square feet of world-class molecular biology, culture collection, physiology, aquaculture, analytical chemistry and engineering laboratories in Fort Myers, Florida. The campus also includes our Process Development Unit (PDU), which itself consists of a 9,500-square foot aquaculture laboratory, two large inoculation greenhouses and 3 acres of outdoor controlled testing area for initial deployment and optimization activities.
In October 2011, we broke ground on the Department of Energy sponsored pilot-scale Integrated Biorefinery in Fort Myers on 36 acres adjacent to the PDU. The Integrated Biorefinery will have the capacity to produce 100,000 gallons of ethanol per year and will contain 3,000 photobioreactors on 17 “wetted” acres, along with supporting processes and infrastructure collectively providing a microcosm of a commercial facility. Upon completion of the Integrated Biorefinery in 2012, Algenol established perhaps the most sophisticated algae facility in the world where an algae strain can go from lab-scale development to commercial-scale production on one site.
Algenol’s corporate headquarters are located in Bonita Springs, Florida, only 15 minutes from the research facility.
With our subsidiary, Algenol Biofuels Germany GmbH (formerly, Cyano Biofuels GmbH), we also have an international team of 50 highly qualified researchers working in a molecular biology laboratory in Berlin, Germany. Established in 2007, the operation was primarily focused on algal biology research and development and, in October 2010, became a wholly owned subsidiary of Algenol. Our operation in Berlin is recognized within the European scientific community as an outstanding partner in various collaborative projects.
Algenol Biofuels Switzerland GmbH, another wholly owned subsidiary, manages our international operations. It is located in Zug, Switzerland and oversees all non-US research, development and finance activities, as well as international licensing and project development.